ENTITY
SIGX1094
SIGX1094
PulseAugur coverage of SIGX1094 — every cluster mentioning SIGX1094 across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-10-30 research_milestone Higgs Bio's AI-developed drug candidate SIGX1094 was nominated for the Prix Galien USA award, highlighting advancements in AI-driven drug discovery. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Higgs Bio's AI-developed cancer drug nominated for Prix Galien award
Higgs Bio, a company incubated by Crystal Pharma, has been nominated for the Prix Galien USA for its AI-developed diffuse gastric cancer targeted drug, SIGX1094. This nomination highlights the success of their "AI + Org…
-
Mura Bio targets immune cell metabolism for autoimmune disease treatments
Mura Bio, a startup co-founded by Dr. Xu Ke, is developing novel treatments for autoimmune diseases by targeting the metabolic pathways of immune cells. Their lead candidate, MP-5342, is an oral LDHA inhibitor designed …